Eurofins Scientific SE (ERFSF) Q4 2025 Earnings Call January 29, 2026 9:00 AM EST
Company Participants
Gilles Martin – Chairman of the Board & CEO
Conference Call Participants
Thomas Burlton – BNP Paribas, Research Division
Suhasini Varanasi – Goldman Sachs Group, Inc., Research Division
Delphine Le Louet – Bernstein Institutional Services LLC, Research Division
Remi Grenu – Morgan Stanley, Research Division
Allen Wells – Jefferies LLC, Research Division
François Digard – Kepler Cheuvreux, Research Division
Presentation
Operator
Ladies and gentlemen, welcome, and thank you for joining Eurofins 2025 Full Year Results. Please note that this call is being recorded and will be — will later be available for replay on the Eurofins Investor Relations website. [Operator Instructions] During this call, Eurofins management may make forward-looking statements, including, but not limited to, statements with respect to outlook and the related assumptions.
Management will also discuss alternative performance measures such as organic growth and EBITDA, which are defined in the footnotes of our press releases. Actual results may differ materially from objectives discussed. Risks and uncertainties that may affect Eurofins’ future results include, but are not limited to, those described in the Risk Factors section of the most recent Eurofins’ annual and half year reports. Please also read the disclaimer on Page 2 of this presentation, subject to which this call and Q&A session are made.
I would now like to turn the conference over to Dr. Gilles Martin, Eurofins’ CEO. Please go ahead.
Gilles Martin
Chairman of the Board & CEO
Thank you, Andrew, and hello, everybody, and thank you for joining our full year 2025 results call. I will keep — we have a long slide show, but I will not go through every slide. I have to give apologies for Laurent Lebras, our CFO, who is not well today. So I will not go in great detail through the financial slide and leave time
Credit: Source link
